- 6
- 0
- 约6.47万字
- 约 50页
- 2023-09-21 发布于湖北
- 举报
The journey to improved outcomes
in transthyretin amyloid
cardiomyopathy (ATTR-CM)
Nina Ajmone Marsan Pablo García-Pavía
Perry Elliott Thibaud Damy
PP-VYN-GLB-1998; August 2023 ©2023 Pfizer Inc. All rights reserved
We welcome your questions and feedback
Please scan the QR codes around the room or use the congress app to submit
your questions for the faculty
You can also use the microphones to ask your questions during the
QA session
原创力文档

文档评论(0)